Use of Dietary Supplements in Patients at Risk of Abortion Treated With Progesterone.

Lo.Li.Pharma s.r.l63 enrolled

Overview

The trial aims to investigate the effect of supplementation with hyaluronic acid, alpha-lipoic acid, magnesium, vitamin D and vitamin B6 in progesterone-treated pregnant women with risk factors for abortion.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

Conditions

Pregnancy, High Risk

Interventions

HADIETARY_SUPPLEMENT

hyaluronic acid, alpha-lipoic acid, vitamin D and vitamin B6

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 50 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Women with risk factor for abortion (sub-chorionic hematoma during gestation or ART procedures) Exclusion Criteria: * Other pregnancy-related conditions * Diabetes or hypertension * Concomitant pharmacological therapies (anticoagulant or antihypertensive) * Use of tocolytic drugs two months prior to enrollment * Association with hypoglycemic drugs

Locations (1)

Clinica Alma Res

Rome, Italy

Outcomes

Primary Outcomes

reduction of the abortion rate

rate of abortion

Time frame: 1 day (single time-point before week 20 of gestation)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.